Skip to main content

Advertisement

ADVERTISEMENT

Volume 21 - Issue 1 - January, 2009

Feature

Original Contribution
01/06/2009
Shyam Poludasu, MD, Erdal Cavusoglu, MD, Waqas Khan, MD, Jonathan D. Marmur, MD Author Affiliations: From SUNY Downstate Medical Center, Brooklyn, New York. The authors report no conflicts of interest regarding the content herein. Manuscript submitted July 14, 2008, provisional acceptance given September 8, 2008, final version accepted October 3, 2008. Address for correspondence: Jonathan D. Marmur, MD, FACC, SUNY Downstate Medical Center, Cardiology, 450 Clarkson Avenue, Box 1257, Brooklyn, NY 11203. E-mail: jonathan@marmur.com
Shyam Poludasu, MD, Erdal Cavusoglu,...
ABSTRACT: Background. Studies on body mass index (BMI) and post-percutaneous coronary intervention (PCI) outcomes have suggested an “obesity paradox” (lower post-PCI mortality rates in obese patients compared to patients of normal weight)....
ABSTRACT: Background. Studies on body mass index (BMI) and post-percutaneous coronary intervention (PCI) outcomes have suggested an “obesity paradox” (lower post-PCI mortality rates in obese patients compared to patients of normal weight)....
ABSTRACT: Background. Studies on...
01/06/2009
Journal of Invasive Cardiology
Original Contribution
01/06/2009
*Sune Haahr-Pedersen, MD, §Mette Bjerre, PhD, §Allan Flyvbjerg, MD, DmSci, Prof, *Rasmus Mogelvang, MD, PhD, *Helena Dominquez, MD, PhD, §Troels Krarup Hansen, MD, DmSci, *Søren Galatius, MD, DmSci, *Jan Bech, MD, PhD, *Jan Kyst Madsen, MD, DmSci, *Peter Søgaard, MD, DmSci, *,£Jan Skov Jensen, MD, PhD, DmSci Author Affiliations: From the *Department of Cardiology P, Gentofte University Hospital, Denmark, the §Medical Research Laboratories, Clinical Institute and Medical Department M (Diabetes and Endocrinology), Aarhus University Hospital, Denmark, and the £Clinical Institute of Surgery and Internal Medicine, Faculty of Health Sciences, University of Copenhagen, Denmark. The authors report no conflicts of interest regarding the content herein. Manuscript submitted July 8, 2008, provisional acceptance given August 18, 2008, and final version accepted October 21, 2008. Address for correspondence: Sune Haahr-Pedersen, MD, Department of Cardiology P, Gentofte Hospital Niels Andersens Vej 65, DK-2900, Copenhagen, Denmark. E-mail: sunped01@geh.regionh.dk
*Sune Haahr-Pedersen, MD, §Mette Bj...
Treated with Primary Percutaneous Coronary Intervention ABSTRACT: Background. The positive effect of reperfusion after ST-elevation myocardial infarction (STEMI) can be reduced by ischemic/reperfusion (I/R) injury. Mannose-binding-lectin...
Treated with Primary Percutaneous Coronary Intervention ABSTRACT: Background. The positive effect of reperfusion after ST-elevation myocardial infarction (STEMI) can be reduced by ischemic/reperfusion (I/R) injury. Mannose-binding-lectin...
Treated with Primary...
01/06/2009
Journal of Invasive Cardiology
Original Contribution
01/06/2009

Khalil A. Kaid, MD, Rajeev Gopinathapillai, MD, Fang Qian, MD, Madhu Salvaji, DO, Najam Wasty, MD, Marc Cohen, MD Author Affiliations: From the Newark Beth Israel Medical Center, Newark, New Jersey.

The authors report no conflicts of interest regarding the content herein. Manuscript submitted July 28, 2008, provisional acceptance given September 24, 2008, final version accepted October 22, 2008.

Address for correspondence: Khalil A. Kaid, MD, Newark Beth Israel Medical Center, Department of Cardiology, 201 Lyons Avenue, Newark NJ 07112. E-mail: drkaid@yahoo.com

Khalil A. Kaid, MD, Rajeev Gopinathap...
ABSTRACT: Purpose. To evaluate the occurrence, size and composition of embolized debris captured during routine directional atherectomy using the SilverHawk device. Methods. 15 consecutive eligible patients with a nonocclusive superficial...
ABSTRACT: Purpose. To evaluate the occurrence, size and composition of embolized debris captured during routine directional atherectomy using the SilverHawk device. Methods. 15 consecutive eligible patients with a nonocclusive superficial...
ABSTRACT: Purpose. To evaluate...
01/06/2009
Journal of Invasive Cardiology
Original Contribution
01/06/2009

a,bCharles Maynard, PhD, cSunil V. Rao, MD, dMary Gregg, MD, MHA, aRichard C. Phillips, MD, MPH, dMark Reisman, MD, eEben Tucker, MD, eJ. Richard Goss, MD, MPH Author Affiliations: From the aDepartment of Health Services, University of Washington, Seattle, Washington, the bDepartment of Veterans Affairs Health Services Research and Development, Seattle, cDuke Clinical Research Institute, Durham, North Carolina, dSwedish Health Services Seattle, and the eDepartment of Medicine, University of Washington, Seattle, Washington.

This study was supported by the Clinical Outcomes Assessment Program, Foundation for Health Care Quality, Seattle, Washington.

The authors report no conflicts of interest. Manuscript submitted August 29, 2008, provisional acceptance given October 28, 2008, final version accepted November 3, 2008.

Address for correspondence: Charles Maynard, PhD, 1100 Olive Way, Suite 1400, Seattle, WA 98104. E-mail: cmaynard@u.washington.edu

a,bCharles Maynard, PhD, cSunil V. R...
For Percutaneous Coronary Interventions in the Clinical Outcomes Assessment Program ABSTRACT: Published mortality models for percutaneous coronary intervention (PCI), including the Clinical Outcomes Assessment Program (COAP) model, have not...
For Percutaneous Coronary Interventions in the Clinical Outcomes Assessment Program ABSTRACT: Published mortality models for percutaneous coronary intervention (PCI), including the Clinical Outcomes Assessment Program (COAP) model, have not...
For Percutaneous Coronary...
01/06/2009
Journal of Invasive Cardiology

Insights

Commentary
01/06/2009
David M. Shavelle, MD Author Affiliations: From the Los Angeles County/Harbor UCLA Medical Center, Los Angeles BioMedical Research Institute at Harbor UCLA Medical Center, Division of Cardiology, Harbor UCLA Medical Center, Torrance, California. The author reports no conflict of interest regarding the topic herein. Address for correspondence: David M. Shavelle, MD, FACC, FSCAI, Associate Clinical Professor of Medicine, David Geffen School of Medicine at UCLA, Director, Interventional Cardiology Fellowship, Los Angeles County/Harbor UCLA Medical Center, Los Angeles BioMedical Research Institute at Harbor UCLA Medical Center, Division of Cardiology, Harbor UCLA Medical Center, Torrance, CA 90509. E-mail: dshavelle@hotmail.com
David M. Shavelle, MD Author Affilia...
J INVASIVE CARDIOL 2009; 21:11-12 Endovascular treatment for peripheral vascular disease continues to evolve.1,2 Among the many devices available for endovascular intervention, atherectomy offers several potential advantages. SilverHawk...
J INVASIVE CARDIOL 2009; 21:11-12 Endovascular treatment for peripheral vascular disease continues to evolve.1,2 Among the many devices available for endovascular intervention, atherectomy offers several potential advantages. SilverHawk...
J INVASIVE CARDIOL 2009;...
01/06/2009
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement